- Home
- / Legend Biotech
Legend Biotech
Stock Price
$60.5
2023-11-24
Market Capitalization
$11 B
2023-11-24
Revenue
$117 M
FY, 2022
Legend Biotech Summary
Company Summary
- Overview
- Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma.
- Type
- Public
- Status
- Active
- Founded
- 2014
- HQ
- Somerset, NJ, US | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Ying Huang, Chief Financial Officer
Meeta Chatterjee, Senior Vice President, Global Business Development
Tracy Luo, Vice President, Clinical Development
LocationsView all
5 locations detected
Somerset, NJ HQ
United States
2101 Cottontail Lane
Piscataway, NJ
United States
10 Knightsbridge Road
Ghent, Vlaams Gewest
Belgium
Technologiepark 122
Nanjing
China
No. 6 Building, Life Science TechTown, 568 Longmian Avenue
Dublin, County Dublin
Ireland
10A Ballymoss Road, Sandyford Business Park
Legend Biotech Financials
Summary Financials
- Revenue (FY, 2022)
- $117.0M
- Gross profit (FY, 2022)
- $51.6M
- Net income (FY, 2022)
- ($446.3M)
- Cash (FY, 2022)
- $786.0M
- Enterprise value
- $10.5B